|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mayer RJ, Venook AP and Schilsky RL:
Progress against GI cancer during the American society of clinical
oncology's first 50 years. J Clin Oncol. 32:1521–1530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WQ, Zheng RS, Zhang SW, Zeng HM and
Zou XN: The incidences and mortalities of major cancers in China,
2010. Chin J Cancer. 33:402–405. 2014.PubMed/NCBI
|
|
4
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wynn TA, Chawla A and Pollard JW:
Macrophage biology in development, homeostasis and disease. Nature.
496:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu H, Xu JB, He YL, Peng JJ, Zhang XH,
Chen CQ, Li W and Cai SR: Tumor-associated macrophages promote
angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol.
106:462–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pollard JW: Trophic macrophages in
development and disease. Nat Rev Immunol. 9:259–270. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murray PJ, Allen JE, Biswas SK, Fisher EA,
Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence
T, et al: Macrophage activation and polarization: Nomenclature and
experimental guidelines. Immunity. 41:14–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Han G, Wang K, Liu G, Wang R, Xiao
H, Li X, Hou C, Shen B, Guo R, et al: Tumor-derived GM-CSF promotes
inflammatory colon carcinogenesis via stimulating epithelial
release of VEGF. Cancer Res. 74:716–726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nebiker CA, Han J, Eppenberger-Castori S,
Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E,
Angrisani B, et al: GM-CSF production by tumor cells is associated
with improved survival in colorectal cancer. Clin Cancer Res.
20:3094–3106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eubank TD, Roberts RD, Khan M, Curry JM,
Nuovo GJ, Kuppusamy P and Marsh CB: Granulocyte macrophage
colony-stimulating factor inhibits breast cancer growth and
metastasis by invoking an anti-angiogenic program in tumor-educated
macrophages. Cancer Res. 69:2133–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sielska M, Przanowski P, Wylot B,
Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J,
Vinnakota K, Kettenmann H, et al: Distinct roles of CSF family
cytokines in macrophage infiltration and activation in glioma
progression and injury response. J Pathol. 230:310–321. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Wang X, Shen Z, Xu J, Qin J and
Sun Y: Infiltration of diametrically polarized macrophages predicts
overall survival of patients with gastric cancer after surgical
resection. Gastric Cancer. 18:740–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang
W, Xiong YQ, Wu WZ, Wang L, Tang ZY and Sun HC: High expression of
macrophage colony-stimulating factor in peritumoral liver tissue is
associated with poor survival after curative resection of
hepatocellular carcinoma. J Clin Oncol. 26:2707–2716. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sica A, Schioppa T, Mantovani A and
Allavena P: Tumour-associated macrophages are a distinct M2
polarised population promoting tumour progression: Potential
targets of anti-cancer therapy. Eur J Cancer. 42:717–727. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda
S, Tachibana M, et al: The degree of macrophage infiltration into
the cancer cell nest is a significant predictor of survival in
gastric cancer patients. Anticancer Res. 23:5015–5022.
2003.PubMed/NCBI
|
|
23
|
Ishigami S, Natsugoe S, Tokuda K, Nakajo
A, Okumura H, Matsumoto M, et al: Tumor-associated macrophage (TAM)
infiltration in gastric cancer. Anticancer Res. 23:4079–4083.
2003.PubMed/NCBI
|
|
24
|
Liu H, Shen Z, Wang X, Zhang H, Qin J, Qin
X, Xu J and Sun Y: Increased expression of C-C motif ligand 2
associates with poor prognosis in patients with gastric cancer
after gastrectomy. Tumor Biol. 37:3285–3293. 2016. View Article : Google Scholar
|
|
25
|
Oda T, Kanai Y, Oyama T, Yoshiura K,
Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S: E-cadherin
gene mutations in human gastric carcinoma cell lines. Proc Natl
Acad Sci USA. 91:1858–1862. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshiura K, Kanai Y, Ochiai A, Shimoyama
Y, Sugimura T and Hirohashi S: Silencing of the E-cadherin
invasion-suppressor gene by CpG methylation in human carcinomas.
Proc Natl Acad Sci USA. 92:7416–7419. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hansford S, Kaurah P, Li-Chang H, Woo M,
Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K,
Zogopoulos G, et al: Hereditary diffuse gastric cancer syndrome:
CDH1 mutations and beyond. JAMA Oncol. 1:23–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Galluzzi L, Senovilla L, Zitvogel L and
Kroemer G: The secret ally: Immunostimulation by anticancer drugs.
Nat Rev Drug Discov. 11:215–233. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guiducci C, Vicari AP, Sangaletti S,
Trinchieri G and Colombo MP: Redirecting in vivo elicited tumor
infiltrating macrophages and dendritic cells towards tumor
rejection. Cancer Res. 65:3437–3446. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saccani A, Schioppa T, Porta C, Biswas SK,
Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A and Sica A:
P50 nuclear factor-kappaB overexpression in tumor-associated
macrophages inhibits M1 inflammatory responses and antitumor
resistance. Cancer Res. 66:11432–11440. 2006. View Article : Google Scholar : PubMed/NCBI
|
